News

  • Filter:

  • Filter:

Idorsia enters collaboration with Viatris

The biotech company Idorsia from the canton of Basel-Landschaft and the North American pharmaceutical company Viatris are collaborating on the...

7 free tools for sustainability assessment in startups

As a startup, you navigate the direction, execution, and impact of your business. How does sustainability fit into this picture?...

Connecting entrepreneurs across borders: the Trinational Entrepreneurship Forum 2023

To build a business in the trinational region, entrepreneurs need a good overview of resources and helpful partners. The Trinational...

Healthtech and the digital healthcare revolution

From drug discovery to the management of chronic illnesses, how are digital solutions transforming the healthcare industry? This article, originally...

Basel Area records impressive startup year 2023

In 2023, a total of 30 startups from the Basel Area received fresh capital from investors. Between them, they banked...

Cheplapharm has major plans for the Basel Area

Cheplapharm Switzerland will seek to drive the growth of the group, and execute global acquisitions of established medicines from large...

Basel-Stadt expands innovation promotion

The canton of Basel-Stadt is increasing its innovation funding to a total of 67 million Swiss francs by 2030. Existing...

The rise of AI and data in pharmaceutical and chemical manufacturing

In our 13th iteration of the Technology Circle (24.10.23), we had a new record of 9 guest speakers! In 10–25...

Noor Biotech opts to establish location in Basel

Noor Biotech has established a presence in Basel. The startup, which is managed by its Saudi Arabian co-founder Nuha Alakhmimi,...

UPM Biomedicals chooses the Basel Area as European bridgehead

UPM Biomedicals is opening a lab on the Main Campus of Switzerland Innovation Park Basel Area. The Finnish company specializes...

Macrogen establishes foothold in Basel

Macrogen Europe is set to move into the Switzerland Innovation Park Basel Area at Novartis Campus. As with its parent...

Scailyte and Artbio making headlines in Basel

The biotech company Scailyte has raised 8 million US dollars as part of a Series A financing round. For its...

Five startups advance to final phase of DayOne Health 4.0

Five international healthtech startups – including the Bern-based startup machineMD – have made it to the final phase of DayOne...

Four new buildings for Switzerland Innovation Park Basel Area

The Switzerland Innovation Park Basel Area in Allschwil in the canton of Basel-Landschaft is set to be expanded from 50,000...

Boehringer Ingelheim acquires T3 Pharma

Boehringer Ingelheim has acquired T3 Pharma, which is based in the Switzerland Innovation Park Basel Area, for an amount of...

Roche investing an additional 1.2 billion Swiss francs in Basel

Roche will be putting an additional 1.2 billion Swiss francs towards the renovation of its site in Basel. This investment...

Nouscom secures 67.5 million euros in financing

Biotech company Nouscom has raised 67.5 million euros in a series C financing round. The Basel-based firm intends to use...

Celebrating six months of innovation: i4Challenge accelerator New Ideas 2022/2023

On the 5th of July 2023, the 3rd iteration of the i4Challenge accelerator program New Ideas came to its conclusion....

How open innovation in healthtech hubs is fueling the rise of digital healthcare

How the ever-increasing uptake of digital solutions is enhancing patient engagement, increasing access to care and lowering the cost of...

How to access the U.S. market with your medical device

In one of our latest Venture Mentoring events by Basel Are Business & Innovation, we invited Nila-Pia Rähle to speak...

Paradigm shift in pain management

Pain is a crucial sensation for survival, but it can also drive us to depression and long-term suffering if not...

BOOM Summit in Basel accelerates health technology

The BOOM Summit at Messe Basel in April 2024 will be a completely new kind of healthcare conference. The first...

Investors stump up 3.7 million Swiss francs in Onena Medicines

Onena Medicines has secured an investment of 3.7 million Swiss francs. The portfolio company of the biotech startup incubator BaseLaunch...

CSL joins Basel Area biotech cluster

The research and development department of the globally active Australian biotech company CSL has moved into a new office in...

Palto Therapeutics receives 150,000 Swiss francs from Venture Kick

Allschwil-based Palto Therapeutics has won the third stage of the Venture Kick promotional funding program. As such, the company now...

Roche uses artificial intelligence for cancer diagnosis

Roche is teaming up with Ibex Medical Analytics and Amazon Web Services in the field of artificial intelligence. The goal...

Cimeio collaborating with the University of Pennsylvania

The Basel-based startup Cimeio has been offered an exceptional opportunity for a preclinical research collaboration with the University of Pennsylvania,...

i4Challenge 2023: 11 winning projects push the boundaries of innovation

With the i4Challenge program running for the sixth time, 6 “Innovative Solutions” and 5 “New Ideas” winners showcase their expertise...

Opportunities in the Metaverse

In our 12th iteration of the Technology Circle (21.06.2023), we learned from four speakers what the metaverse is and what...

biGENIUS receives 2 million euros for new cloud product

Software company biGENIUS, based in the Basel Area, has secured financing of 2 million euros. This funding was granted following...

Opterion Health secures investment of 6.5 million Swiss francs

Opterion Health has raised a total of 6.5 million Swiss francs as part of a financing round. The company, which...

TOLREMO receives 39 million US dollars in investments

TOLREMO Therapeutics has concluded a series A funding round with 39 million US dollars. The biotech company based in Basel...

Mazars opens tenth Swiss office in Basel

Mazars is now also present in Basel with a subsidiary as of September 1. This is the tenth Swiss location...

Medtech in Switzerland – bringing together traditional skills and hightech industry

How the intersection of traditional and novel skillsets in the Jura area is propelling Switzerland into a new era of...

Fondation Botnar supporting further research into pediatric health

The Basel-based Botnar Research Centre for Child Health has received a further donation of 50 million Swiss francs from the...

Forty51 Ventures invests to found Mysthera Therapeutics

Mysthera Therapeutics AG has been founded in Basel. Forty51 Ventures, a venture capital firm also based in Basel, has provided...

Spexis receives capital commitment of 2.5 million US dollars

Investors have made an additional capital commitment to Spexis AG, based in the Basel Area. With an extra 2.5 million...

Worg secures financing of 130 million Swiss francs

The Chinese biopharmaceutical firm Worg Pharma, whose European headquarters are located in the Basel Area, has secured gross proceeds equivalent...

Tenpoint aims to make vision loss reversible

The startup Tenpoint Therapeutics has started operations with a funding round of 70 million US dollars. It works to make...

Roche and ETH training the next generation of researchers

Roche, the Basel-based life sciences firm, and the Swiss Federal Institute of Technology in Zurich (ETH) are joining forces to...

Clear Solutions Labs seeks to benefit from the Basel Area

The founders of Clear Solutions Laboratories are putting together a team of experts in the fields of biotechnology, pharmaceutical science...

AI for SMEs – The complete guide to implementing AI in your manufacturing company

Over 3 years, we developed a guide to implementing AI in your manufacturing company. Learn about our progress and be...

QuantumBasel offers access to the world’s most powerful quantum computers

QuantumBasel has consolidated its status as a neutral quantum hub with access to the world’s best quantum computers through a...

How digital transformation is driving pharmaceutical innovation in Basel

How are digital innovations such as artificial intelligence and machine learning helping to improve drug research and development? Digital technologies...

Medical informatics is shaping Switzerland’s digital future

Switzerland is at the forefront of embracing medical informatics, and innovative biotech hubs – such as the Basel Area –...

Ground-breaking oncology being developed in the Basel Area

The Basel Area – covering northwestern Switzerland – has seen tremendous growth in recent years, and has become a true...

Genedata expanding its user network

The Japanese biopharmaceutical firm Ajinomoto is to use the Genedata solution to accelerate its drug development processes at its site...

How Moderna is growing in Switzerland

The number one rule in real estate is “Location, Location, Location.” The global biotech company Moderna found its location in...

Sandoz decides on Basel for headquarters

Sandoz AG will continue to have its headquarters in Basel as an independent company. The separation from Novartis is expected...

VectivBio sold for approximately 1 billion dollars

The takeover of VectivBio is now being finalized: the Boston-based firm Ironwood Pharmaceuticals, which specializes in gastrointestinal medicine, has agreed...

University of Basel and RocketVax present new Covid vaccine

Researchers from the University of Basel have developed a new concept for a Covid vaccine in collaboration with the biotech...

AI engineering and its impact on business

Learn how AI is changing the game of innovation, its role in product development and what companies have to do...

Rami Swiss and Elbit Systems now manufacturing in Jura

The newly established company Rami Swiss has inaugurated a new production facility in Courtételle in the canton of Jura together...

Basel to become Europe’s Silicon Valley of biotech

Silicon Valley is synonymous with technology and innovation, and home to dozens of Fortune 1000 companies and thousands of startups....

Roche and Novartis among global leaders for research spending

In 2022, Roche invested 16 billion euros in research and development overall. This puts the Basel-based life sciences firm in...

Roche to found Institute for Human Biology

Roche has announced that it will be establishing the Institute of Human Biology in Basel. Up to 250 employees will...

Provectis establishes presence in Basel

Provectis Healthcare has chosen Basel as the location for its headquarters. The company is striving to become the partner of...

Sustainability reporting is a must for startups

In recent years, sustainability has become an increasingly important consideration for businesses of all sizes, including startups. Large companies have...

Alentis raises 105 million US dollars

Alentis Therapeutics has received 105 million US dollars in a series C funding round. It will invest the funds in...

Innovation and collaboration to prepare your company for the future

The world is changing faster than ever. Since COVID, office culture has shifted massively. With ChatGPT, AI has become accessible...

Spirecut establishes presence in the Basel Area

Spirecut has opted to establish its new headquarters in the canton of Basel-Landschaft. The company is now operating out of...

Evolva launches new line for manufacturers of personal care products

Evolva, a manufacturer of active ingredients based in Reinach in the canton of Basel-Landschaft, will be presenting its new product...

Record figure for startups in the Basel Area

Basel Area Business & Innovation has supported a record number of 96 company startups in 2022. The number of settlements...

Noema Pharma raises 103 million Swiss francs from investors

Noema Pharma has raised a total of 103 million Swiss francs as part of an oversubscribed Series B financing round....

Why CDMO companies choose the Basel Area as their location

This article highlights the increasingly important issue of location for contract development and manufacturing organizations (CDMOs), and discusses how elements...

No one too small to make a difference

This article introduces the Swiss Triple Impact and summarizes the keynote held by Martin Studer, the 25th of August at...

Basel still the most attractive small city for business in Europe

As with last year, Basel once again features among the most attractive locations in Europe for investments. It was ranked...

Cities and regions can drive demand for sustainable business models

This article introduces the Solar Impulse Foundation and summarizes the keynote held by Robin Henri on the 25th of August...

Ariceum Therapeutics establishes subsidiary in Basel

The German life sciences firm Ariceum Therapeutics has established a subsidiary in Basel. This company has received support from Basel...

RocketVax raises fresh capital

The Basel-based biotech startup RocketVax has successfully closed another financing round. This additional funding will primarily be used to further...

Clinerion is now part of Citeline

Clinerion has been integrated into New York-based company Citeline. Clinerion plans to expand its portfolio with Citeline’s complementary opportunities with...

KUORI developing biodegradable plastics

The Basel-based cleantech company KUORI GmbH develops alternative materials for conventional plastics. The aim is to reduce the accumulation of...

Why business design is key for a sustainable economy

The economy is overshooting planetary boundaries – and companies play a crucial role to do better. Learn to define and...

Cell and gene therapies gain momentum in Basel

Companies specializing in the research and development of innovative cell and gene therapies continue to spring up all around the...

Digital twins and data visualization in Industry 4.0

We invited five speakers to talk about digital twins, data visualization and the Building Information Modeling (BIM) used in the...

BLKB expanding support for startups

BLKB offers particularly promising SMEs and startups financial support within the framework of the “100 fürs Baselbiet” program. These companies...

Cyber security for the digitized and networked world

No company is safe from cybercriminals. Everyone has heard of hacker attacks, but few companies are really prepared.

Combatting the rise of antimicrobial resistance

Antimicrobial resistance is a growing global threat that, without intervention, could lead to as many as 10 million deaths annually...

AMR Action Fund invests in new antibiotics developed by BioVersys

The AMR Action Fund has made its first European investment in BioVersys, which is headquartered at Tech Park Basel. The...

Investors give Resistell 8.5 million Swiss francs

Resistell AG has secured 8.5 million Swiss francs in the first part of its series B funding round. The biotechnology...

BSI integrating AI from Parashift in banking software

Parashift, the specialist in the area of smart document processing on the basis of Artificial Intelligence (AI), has entered into...

Europe’s booming biotech powerhouse is called Basel

The first places to spring to mind when most people think of “life sciences hubs” are long-established, high-profile geographical locations...

UptownBasel joins IBM Quantum Network

UptownBasel is partnering with IBM. The emerging competence center for Industry 4.0 will provide its partners with the IBM Quantum...

South Korean pharma firms show interest in the Basel Area

Several South Korean firms from the life sciences industry, including three pharmaceutical multinationals, have visited the Basel Area on fact-finding...

Gamma Technologies acquires ProFEMAG portfolio

The Basel-based firm ProFEMAG AG has sold its FEMAG software for electrical machine applications to Gamma Technologies. The company based...

Databaum establishes headquarters in Basel

Databaum is establishing its headquarters in Basel and plans to grow from its location there. The startup provides the agricultural...

Clinerion launches patient information platform

Basel-based Clinerion is introducing its machine learning platform. It comprises a global network of hospitals and enables researchers to recognize...

New innovation campus opens in the Basel Area

The Main Campus of the Switzerland Innovation Park Basel Area was officially opened on October 29. In his speech, Federal...

Sumitovant acquires all shares in Myovant

Sumitovant is in the process of making Basel-based Myovant Sciences a wholly owned subsidiary by acquiring a 100 percent shareholding...

VectivBio raises 125 million US dollars in stock sale

VectivBio has announced the closing of the subscription offer for 16,700,000 ordinary shares. The Basel-based biotechnology firm has generated gross...

KetoSwiss secures capital increase of 4 million dollars

KetoSwiss has banked a total of 4 million US dollars from investors. The Basel-based startup develops products to alleviate neurological...

Escientia Switzerland becomes Primopus

The Indian company Deccan Fine Chemicals is acquiring Escientia Switzerland and renaming it as Primopus AG. The new owner announces...

The i4Challenge boosts great solutions for the Industry 4.0

For the 5th time, we award the i4Challenge winners. The six winners “Innovative Solutions” not only developed convincing solutions, but...

Novartis investing 100 million Swiss francs in new biologics center

The pharmaceutical company Novartis is investing a sum of 100 million Swiss francs in a new competence center for biologics...

Official opening of the competence center uptownBasel

uptownBasel celebrated its official opening. Technology companies such as Bouygues and Vinci Energies are already occupying the first building of...

Eight startups from Basel Area feature in TOP 100 Swiss Startups

Among the most promising startups in Switzerland eight companies from Basel Area's startup ecosystem have been named. They are some...

Roche opens tallest building in Switzerland

Roche has inaugurated a new office building with 3,200 positions in Basel. Standing 205 meters high, Building 2 is the...

DayOne Tech supports three medtech startups

DayOne, the healthcare innovation initiative from Basel Area Business & Innovation, has started its medtech accelerator in the canton of...

BioFi AG newly settles in Basel

BioFi has set up its headquarters in Basel. The company has emerged from Crowley Davis Research, which was established in...

Forty51 closes first fund totaling 43 million US dollars

A new Basel-based venture fund, Forty51 Ventures I, has raised a total of 43 million US dollars following a first...

AstraZeneca and docdok.health improving asthma control

AstraZeneca and the Basel-based startup docdok.health are jointly developing a new digital solution to treat chronic respiratory diseases. Studies at...

Basel Area achieves milestone with settling of LifeMine

Life sciences company LifeMine Therapeutics from the USA has established its European headquarters in the Basel Area. With this, Basel...

Space Pharmaceuticals establishes presence in Basel

Space Pharmaceuticals AG is strengthening the life sciences cluster in the Basel Area. At its research lab, the cheminformatics company...

What’s fueling Basel Area’s advanced manufacturing ecosystem

The Covid-19 pandemic continues to have an unmistakable effect on the pharmaceutical industry and its manufacturing processes. Learn more about...

NextImmune to benefit from Venture Kick financing

The startup accelerator Venture Kick is supporting NextImmune with financing in the amount of 150,000 Swiss francs. The spin-off from...

OECD impressed by the canton of Jura’s innovation system

The OECD has examined the innovation systems in place in rural areas of its member states, including the canton of...

ti&m opens branch in Basel

ti&m now has an office in Basel. With this action, the company specializing in digitization, security and innovation projects is...

What can artificial intelligence do for health?

What’s the state of artificial intelligence in healthcare? It's potential has been recognized by the medtech industry, health systems, pharmaceutical...

Economic promotion agency creates 55 new jobs in Jura

The economic promotion agency of the canton of Jura supported a total of 26 companies in founding, establishing a presence...

Investors top up capital of BioVersys

BioVersys has raised 24.2 million Swiss francs in a series C funding round. The Basel-based pharmaceutical company plans to use...

Swiss made software label awarded to 1000th company

Swiss made software GmbH has now awarded its seal of quality to its 1,000th member firm. The “swiss made software”...

EvokAI to acquire Advancience

EvokAI Creative Labs Inc. has agreed a deal to acquire Advancience. The diagnosis profiles enhanced by Artificial Intelligence (AI) developed...

BeiGene opens European headquarters in Basel

BeiGene has opened its new European headquarters in Basel. The global biotech specializing in innovative cancer treatments intends to build...

The 25 Best AI Courses in the Basel Area, Germany and France

Artificial Intelligence (AI) offers numerous possible applications. But how, where and regarding which focal points can you get further training...

Service design innovation for startups (by three experts)

We’ve held a webinar with three experts on service design: Michele Visciòla, Daniele Catalanotto and Jin Kang Møller.

Engimmune Therapeutics banks 15.5 million Swiss francs

Engimmune Therapeutics will now be in a position to drive forward its innovative platforms for the development of T-cell therapies...

Bionter receives 3 million US dollars in investments

Bionter AG has received 3 million US dollars in a seed funding round. These funds will enable Bionter to bring...

Resistell seeking to further develop test to combat antibiotic resistance

The startup Resistell has launched a study looking into the applicability of a test against antibiotic resistances that is being...

Biotech startup Cimeio receives 46 million Swiss francs for cell therapy

Cimeio Therapeutics from Basel has received initial financing amounting to 46 million Swiss francs from Versant Ventures. The startup is...

Superlab Suisse heading to Basel

Superlab Suisse is bringing its Lab-as-a-Service business concept to Basel. The company will open a new location with lab and...

Swiss TPH opens new building on the site of BaseLink

The Swiss Tropical and Public Health Institute has officially opened its multifunctional new building at the Basel Area’s new life...

World first in the Switzerland Innovation Park Basel Area

Eldico Scientific has opened the world’s first experience center for electron diffractometry in the site Allschwil of the Switzerland Innovation...

DayOne healthtech accelerator launches new offering

DayOne shares the launch of DayOne Accelerator 2.0, marking a transition to three verticals that will enable the growth of...

Basel Area sets new record for new company settlements

For Basel Area Business & Innovation, 2021 was a record year. Last year, the investment and innovation promotion agency supported...

Ginkgo Bioworks to acquire Basel-based firm FGen AG

The US biotechnology firm Ginkgo Bioworks has agreed a takeover deal for the startup FGen. The Basel-based firm develops technologies...

Artificial Intelligence in the Upper Rhine region

In the trinational German-French-Swiss metropolitan region of the Upper Rhine that belongs to the AI European Valley, a number of...

ACROBiosystems establishes presence in the Basel Area

ACROBiosystems headquartered in Beijing has selected the Basel Area to expand its research and commercial activities in Europe.

Basel among the most future-oriented cities in Europe

fDi Intelligence has investigated the most important tech cities across Europe. Basel secured top spot in the category of small...

AMR Action Fund opens European office in Basel

The AMR Action Fund has moved into its new European office in Basel. The venture fund is the largest public-private...

InOpSys heading to Basel

The Belgian company InOpSys is opening a subsidiary in Basel. The supplier of water purification solutions intends to press on...

Basel startups impress investors

According to the latest Swiss Venture Capital Report, investments in Swiss startups increased by 44 percent last year. As a...

Basel Area – exactly the right chemistry for South Korean pharma companies

KPBMA and Basel Area Business & Innovation establish tailored collaboration to support Korean biopharmaceutical companies to enter the European market

Basel Area supporting three digital health startups

Basel Area Business & Innovation will be offering intensive support to the three winners of its DayOne Digital Health Accelerator...

Gray establishes presence in Basel

The North American fully integrated specialty service provider Gray has established a subsidiary in Basel. The key factors in favor...

Artificial Intelligence able to identify potentially life-saving antibiotics

A computer algorithm has identified antibiotics that that are still effective against infections in which multi-resistant germs are present. University...

Investors give Anaveon 110 million Swiss francs

Anaveon has received investment commitments amounting to 110 million Swiss francs in a Serie B funding round. The Basel-based biopharmaceutical...

Basel alliance seeks to combat antibiotic resistance

The Spearhead alliance has been founded in Basel with the aim of combating the silent pandemic of antimicrobial resistance. By...

Kinarus and Noorik awarded federal grants

The Basel-based biopharmaceutical companies Kinarus and Noorik have been awarded federal grants for their clinical trials investigating drug candidates to...

Alloy acquires deepCDR and will expand Basel site

Alloy Therapeutics, a biotechnology firm from Boston in the USA, has acquired the Basel-based startup deepCDR Biologics. Alloy labs and...

Basel Healthtech fund successfully closed

The venture capital firm MTIP has announced the successful closing of its FUND II. It is one of the first...

Roche tests able to detect Omicron

The Roche subsidiary TIB Molbiol has developed new coronavirus testing kits that can also detect the new Omicron variant of...

Hemex banks 7.1 million Swiss francs

Hemex has raised a total of 7.1 million Swiss francs as part of a Series C financing round. The company...

EsoCap impresses investors

EsoCap, a biotech company based in Basel, has concluded a successful funding round. The funds from new and existing investors...

Plug and Play settles in the Basel Area

Plug and Play is coming to the canton of Basel-Landschaft. The first founding partner of the innovation promoter from Silicon...

Bachem builds its largest production building

Bachem has laid the foundation stone for its largest production building to date. The company specializing in the manufacture of...

Bottneuro advancing personalized Alzheimer’s therapy

Basel-based startup Bottneuro is working on the development of personalized therapies to treat Alzheimer’s disease in which certain areas of...

Straumann plans to build innovation center in the Basel Area

The Basel-based dental specialist Straumann is planning to construct a new technology and innovation center in Arlesheim in the canton...

Ontotext opens new office in the Basel Area

Ontotext, a company based in New York City and the Bulgarian capital of Sofia, has opened a new location at...

Owkin heads to Basel

The Franco-US startup Owkin is establishing a branch office in Basel. The company develops solutions for the life sciences industry...

Danish AI company settling in the Basel Area

Abzu has settled on the Novartis Campus of the Switzerland Innovation Park Basel Area. From there, the Danish deep tech...

«I always wanted to create something from scratch»

Already when he was young, he was driven to create and invent. Today at the age of 33, Gwenael Hannema...

The i4Challenge announces the winners of 2021

The i4Challenge shines a light on companies and innovators who help to facilitate the industrial transformation. We present the winners...

Basel Area becomes the Swiss hotspot for Chinese pharma companies

More and more Chinese pharmaceutical companies are choosing the Basel Area as location for their subsidiary in Switzerland. Among them...

New offering for digital health startups in the Basel Area

Basel Area Business & Innovation is expanding the offering of its DayOne Accelerator – both in terms of content and...

Botanikind settles in Basel

The internationally active Swiss company Botanikind has settled in Basel and established Botanikind AG there. It provides natural ingredients for...

Kinarus secures capital commitment of 57 million Swiss francs

The biopharmaceutical company Kinarus has signed a capital commitment of up to 57 million Swiss francs with the investment group...

Biotech startups from the Basel Area confirm leading position

As part of the Top 100 Swiss Startup Awards 2021, the most promising startups in Switzerland are honored. These also...

T3 Pharma wins Swiss Economic Award

T3 Pharma has won the Swiss Economic Award 2021. Switzerland’s most prestigious young entrepreneur prize is awarded by the Swiss...

Worg selects Basel Area for European headquarters

Worg Pharmaceuticals has opted to establish its European headquarters at the site Allschwil of the Switzerland Innovation Park Basel Area....

ten23 health settles in Basel

The life sciences cluster Rosental Mitte located in Basel is home to a new, globally active company called ten23 health....

Lumineo installs translucent concrete wall for Vinci

The global construction and energy group Vinci engaged the jurassic Lumineo Group to design a wall made from translucent concrete...

Roivant invests 200 million dollars in Immunovant

The Basel-based Roivant Group has invested a total of 200 million dollars in the US biopharmaceutical company Immunovant. This investment...

Lyfegen collaborating with Johnson & Johnson

The Basel-based startup Lyfegen has developed a platform for value-based healthcare. This should provide improved outcomes for patients and result...

Bottmedical enters the market with innovative braces

The Basel-based startup Bottmedical has developed clear braces made from bio-based polymers. After closing a successful financing round, the company...

TargImmune raises nearly 18 million Swiss francs

The Basel-based biotechnology firm TargImmune has raised 17.7 million Swiss francs as part of a financing round. It now intends...

KetoSwiss launches first product in the USA

The Basel-based biotech startup KetoSwiss develops innovative therapies for neurological disorders. Following a successful capital increase, the company now has...

Basel Area treads unique path

Basel Area is responsible for both location and innovation promotion. This approach, which is unique across Switzerland, is very successful...

Alentis secures 67 million US dollars

The Basel-based biotechnology company Alentis Therapeutics has secured 67 million US dollars in a series B funding round. The funds...

RocketVax secures partners for coronavirus vaccine in Basel

RocketVax has found cooperation partners for the development of its innovative coronavirus vaccine. The University Hospital of Basel, the University...

Bright Peak secures investment of 107 million dollars

Bright Peak has raised a total of 107 million US dollars as part of a financing round. The biotechnology firm...

LCB lands major contract

LCB Sàrl is active in the areas of Human Machine Interface as well as software and electronics development. The company...

Scailyte now calls Basel home

The biotechnology firm Scailyte is now installed at the Novartis Campus of Switzerland Innovation Park Basel Area. Scailyte develops solutions...

Roche gives MRI equipment a second life

Basel-based pharmaceutical and diagnostics company Roche has decommissioned two MRI machines that are no longer in use. One complete device...

BGO Software establishes branch in Basel

The Bulgarian firm BGO Software has now established a presence in Basel after founding BGO Software und Technologie GmbH. The...

ACM Biosciences receives support for Covid-19 vaccine

Innosuisse, the Swiss Innovation Agency, is supporting the Basel-based biotechnology company ACM Biosciences with a grant. This is intended for...

Basilea receives grant for novel antibiotic

The CARB-X initiative is granting a sum of 2.7 million US dollars to the Basel-based pharmaceuticals company Basilea. This will...

Discover the Basel Area as #1 in biotech investment

A total of 700+ life science companies call the Basel Area their home. It has become the premier biotech cluster...

Qnami secures investment of 4 million Swiss francs

Qnami has raised a total of 4 million Swiss francs from investors after successfully closing a Series A financing round....

Marija Plodinec: “I like a good challenge”

As a CEO of a medtech startup looking for funding, you need to do two things extremely well: make sure...

Typewise presents new smartphone keyboard

The startup Typewise is presenting the third generation of its virtual keyboard for smartphones. Typewise 3.0 uses a new patented...

Basel Area starts new i4Challenge

The next round of the i4Challenge support program is getting underway. With this, Basel Area Business & Innovation is striving...

Basel Area shapes future health innovations

A success factor for the Basel Area has been its steady transformation. From chemicals through the pharmaceutical industry to the...

Biggest successes in 2020 for biotechs in the Basel Area

Biotech companies in the Basel Area played a key role in the sector’s record performance in 2020. The latest Swiss...

New innovation campus to be named Switzerland Innovation Park Basel Area Main Campus

A new innovation campus is currently under construction in Allschwil. This will be known as Switzerland Innovation Park Basel Area...

Synendos Therapeutics expands financing to 24 million Swiss francs

Ysios Capital joins the existing consortium of European investors to expand the Series A financing for Synendos Therapeutics. The Allschwil-based...

Innosuisse funding new RocketVax coronavirus vaccine

Leading Swiss experts in immunology and virology have joined forces in the Basel-based startup RocketVax with the aim of developing...

MTIP using new fund to invest in innovative companies

The Basel-based firm MTIP AG specializes in investments in HealthTech companies. A total of 130 million euros has already been...

Technology Circle: Recommended concepts, components and methodologies of transformation strategies

The fourth online Technology Circle Event in February 2021 focused on concepts and components as well as on project methodologies...

Basel Area records successful 2020

Basel Area Business & Innovation was able to newly settle a total of 27 companies in the Basel Area in...

Interview with Neil Goldsmith, Director Strategy, BaseLaunch

“If you want to play on the big stage, then Basel is where you should be.” Neil Goldsmith, Director of...

Titan-e, the transnational network that supports companies in their technological transition

Titan-e is the product of transnational partnerships with the objective of bringing business and science closer together in order to...

BetterDoc opts for Basel

The online medical service BetterDoc has selected Basel as its Swiss location. Together with the health insurance firm Assura, it...

Kybora settles its European headquarters in Basel

The American consultancy Kybora, which operates within the life sciences industry, has established its European headquarters in Basel. Kybora GmbH...

Escientia establishes subsidiary in the Basel Area

The U.S. company Escientia Life Sciences Group has established a subsidiary in the canton of Basel-Landschaft. Escientia Switzerland will offer...

Basel presents itself as center of innovation at the House of Switzerland in Tokyo

Around a dozen innovative companies and institutions from the Basel Area are planning a joint marketing presence in Tokyo under...

MyCamper is a European growth champion

The Financial Times has included the Basel-based firm MyCamper in its list of the 1,000 fastest-growing startups in Europe. MyCamper...

Researchers in Basel develop dual-virus therapy for cancer

Researchers at the University of Basel have developed a promising strategy for therapeutic cancer vaccines. They are expanding upon pre-existing...

BLKB supporting startups in Basel region

Basellandschaftliche Kantonalbank (BLKB) has founded the inQbator startup accelerator. Together with its partners Hemex and Launchpad, the bank will be...

BioVersys receives funding in the fight against tuberculosis

The Basel-based pharma company BioVersys has received 2.7 million euros in funding alongside two partners. This financing serves to help...

Biosynex takes up residence in Delémont

The French company Biosynex develops analytical, diagnostic and prophylactic medical devices. Its portfolio includes a test for Covid-19. It has...

Novartis Campus opening further

Novartis' 25-year anniversary also marks the next step in the ongoing opening of the campus. The Switzerland Innovation Park Basel...

docdok.health increases safety of coronavirus vaccinations

The Basel-based startup docdok.health has developed an app that aims to increase the safety and efficacy of COVID-19 vaccinations. The...

Hemex attracts Swiss investors

A group of experienced Swiss entrepreneurs and private investors have participated in a significantly oversubscribed financing round for Hemex. The...

Rhizen drug secures approval in the USA

The United States Food and Drug Administration has granted accelerated approval for the drug Umbralisib. Basel biotech Rhizen has discovered...

Novaremed secures US$50 million

Basel biotech Novaremed is receiving US$50 million through an agreement with an investment group. Novaremed will use this financing to...

Axtria driving growth from Basel

The US firm Axtria has established a new office in Basel. The company offers services for the life sciences industry...

Technologiepark Basel celebrates its role as a driver of innovation

The Technologiepark Basel will be ten years old in 2021. Over the past decade, it has supported many startups and...

Basel Area has ever more to offer investors

The canton of Basel-Stadt has displayed the most striking performance in the Swiss Venture Capital Report. Last year, more than...

Basel researchers developing universal cancer therapy

Researchers from Basel are working on the development of a therapy in which pre-prepared immune cells can be used to...

Opterion Health AG moving to Muttenz

Opterion is moving from the canton of Obwalden to Muttenz in the canton of Basel-Landschaft in order to benefit from...

Evolva brings natural sugar blocker to market

The biotech company Evolva is introducing L-arabinose to the market. This product is a natural sugar blocker and can be...

Holmusk opens new office in Basel

Holmusk has opened an office in Basel. The company from Singapore develops digital therapies on the basis of data analysis....

Zifo RnD Solutions coming to Basel

Zifo RnD Solutions, a global provider of IT solutions for research-based organizations, opens its latest subsidiary in Basel. With Zifo...

Announcing the chosen ventures for the DayOne Accelerator (2020/2021)

The DayOne Accelerator ventures for 2020/21 have been chosen. Over 100 teams applied for the program which will run from...

«We will show the new product at the Olympic Games 2021 in Tokyo»

The new Basel Area Business & Innovation Podcast offers exciting conversations with interesting interview partners. The first guest is surgeon...

Announcing the final winners of the i4Challenge 2020

The expert jury of the i4Challenge selected this year's winners. The solutions from the field of Industry 4.0 range from...

Patients stand to benefit from innovative tech project

The investment and innovation promotion agency Basel Area Business & Innovation is joining forces with several partners to realize a...

Boehringer Ingelheim acquires Basel’s NBE-Therapeutics

German pharma group Boehringer Ingelheim is to acquire the Basel life sciences company NBE-Therapeutics for €1.18 billion. NBE-Therapeutics specializes in...

Entrepreneurship in the Basel Area — An Interview with Daniel Ginter

Before Daniel joined Basel Area Business & Innovation, he was responsible for corporate innovation and acceleration at digitalswitzerland. He gained...

How the industry can make the most of data management and AI

Data management can play a major role in the digital transformation of the industry: it helps with maintenance, reduces downtime...

Noema Pharma raises 54 million Swiss francs

The Basel-based pharmaceutical company Noema Pharma has raised a total of 54 million Swiss francs as part of a Series...

Meteoblue constantly presents new developments

The meteoblue weather service based in Basel has developed a weather map widget that can be embedded in any website....

Lonza manufactures coronavirus vaccine for Moderna

Lonza plans to start production of Moderna’s coronavirus vaccine in Switzerland before the end of the year. Moderna published the...

Synendos raises 20 million Swiss francs

Synendos Therapeutics has concluded a Series A financing round, raising 20 million Swiss francs. The Basel biotech will use the...

ChemAxon establishes subsidiary in Basel

ChemAxon develops software for application in the chemicals and biopharma industries. Now, the Hungarian company has established a subsidiary in...

DSM strengthens the Basel Area life sciences cluster

The global nutrition and health corporation Royal DSM is establishing a new innovation center at the headquarters of Nutritional Products...

Canton of Jura looking towards robotics

The canton of Jura has for quite some time been a hub for the precision industry. Now, however, companies such...

Novartis agrees cooperation to fight Covid-19

A collaboration between Molecular Partners and Novartis has been announced. Molecular Partners will be responsible for the Phase 1 trials...

An intense and ambitious year for the Jura site of the Switzerland Innovation Park Basel Area

Despite the coronavirus pandemic, which has delayed some projects, the Jura site of the Switzerland Innovation Park Basel Area has...

The action fields of digital transformation

During our Technology Circle Event in autumn 2020 (the second of the Technology Circle program, was conducted online), Prof. Dr....

VectivBio secures investments totaling 110 million dollars

The Basel-based biotechnology firm VectivBio has received a capital injection of 110 million US dollars from both new and existing...

Polyphor receives up to 18 million dollars for development of antibiotics

The Allschwil-based company Polyphor has received a second funding award from the global consortium CARB-X to combat antimicrobial resistance. Polyphor...

DayOne Accelerator applications open

We are excited to announce the opening of the call for the DayOne Accelerator, now in its 3rd year!

Matériaux Sabag printing concrete elements

The Jura-based company Matériaux Sabag is now using a 3D printing solution to produce its concrete elements. This approach allows...

Monte Rosa Therapeutics banks 96 million US dollars

The Basel-based biotechnology firm Monte Rosa Therapeutics has raised a total of 96 million US dollars after closing a successful...

Roche launches new coronavirus antibody test

Roche is launching on the market a new antibody test to determine coronavirus infections. This should help with the development...

Investors see great potential in Polyneuron

The Basel-based company Polyneuron Pharmaceuticals extended its Series A funding round and has now raised a total of 36.5 million...

3 predictions of the future of work

What are the implications of the big reset on the future of work? Frank Kumli takes a look at the...

Lonza set to manufacture coronavirus drug for Humanigen

The Basel-based pharmaceutical supplier Lonza is supporting the US firm Humanigen in the development of a potential coronavirus therapeutic. Lonza...

Startups from the Basel Area ranked among the best

Startups from the Basel Area have been ranked highly in the TOP 100 Swiss Startup Award by Venturelab. The medtech...

Roche testing for coronavirus and flu simultaneously

The U.S. Food and Drug Administration has given the Basel-based life sciences company Roche authorization to use a test that...

Hengrui Medicine sets up clinical research and development in Basel

The Chinese life sciences company Hengrui Medicine is establishing a Swiss subsidiary in Basel. The European hub for clinical research...

Polyphor awarded exclusive licensing agreement for China

The Basel Area-based company Polyphor has signed an exclusive licensing agreement with Fosun Pharma in China. Fosun Pharma will lead...

New label guarantees that data remains in Switzerland

With the new “swiss hosting” label, the Basel-based company swiss made software Gmbh is guaranteeing that data will not be...

Coworking in the Basel Area – An Interview with Karin Crisanto

Karin Crisanto recently joined Basel Area Business & Innovation as Head of Innovation Space and Infrastructure. She previously worked for...

Switzerland ranked in second place globally

The chemical and pharmaceutical industry of Switzerland has been ranked number two in the world after the USA in terms...

Switzerland Innovation Park Basel Area opens site on Novartis Campus

Switzerland Innovation Park Basel Area has opened a new location at the Novartis Campus. From here, the innovation park’s operator,...

Moderna driving forward production of vaccine from Basel

Moderna is opening a location in Basel and is advancing the production of the coronavirus vaccine from there. The Swiss...

Yokogawa establishes innovation center in Allschwil

The Japanese conglomerate Yokogawa has established a Swiss subsidiary based at the Switzerland Innovation Park Basel Area. Here, the focus...

Basel gains new biotech in Bright Peak

Versant Ventures has made a US$35 million Series A funding commitment to Bright Peak Therapeutics and has now announced the...

Robots from Basel set to revolutionize surgery

The Werner Siemens Foundation is to invest an additional 12 million Swiss francs in the Miracle project. Researchers at the...

T3 Pharma raises over 25 million Swiss francs

T3 Pharmaceuticals AG has closed its third financing round, raising over 25 million Swiss francs. The Basel-based startup has developed...

Versameb raises 6 million Swiss francs

The Basel-based biopharmaceutical company Versameb has successfully closed a seed financing round. Versameb develops therapies on the basis of mRNA...

Genedata accelerating drug development

Genedata, a Basel IT company specializing in the life sciences sector, has agreed a collaboration with Thermo Fisher. The integration...

Basel is “probably the most productive life sciences location in the world”

Two thirds of the value added attributable to the pharmaceutical industry as a whole in Switzerland is generated in the...

Basel Area cantons publish joint economic report

The cantons of Basel-Landschaft, Basel-Stadt and Jura have just published their first joint Economic Report. The fundamental environment is described...

Resistell receives high-level EU grant

Resistell AG, based in Muttenz in the canton of Basel-Landschaft, has received a grant of up to 2.5 million euros...

Switzerland Innovation Park Basel Area Site Novartis Campus

We are happy to present our latest addition to the Switzerland Innovation Park Basel Area: Our site on the Novartis...

Artidis ends successful study

Artidis, a startup from Basel, has developed a nanotechnology platform that can be used for cancer diagnosis, among other things....

Startup Academy celebrates anniversary

Startup Academy is on the road to success ten years after being founded. The initiative has supported 280 startups to...

Value-based healthcare: how to sell the obvious?

When talking about healthcare, almost immediately the focus is on cost - not value. This is about to change as...

Tolremo raises additional funding

The Muttenz-based biotechnology company Tolremo Therapeutics has raised an additional 4.7 million Swiss francs as part of a financing round....

Polyneuron medication receives orphan drug status in the USA

The American health authority has granted Polyneuron’s drug PN-1007 orphan designation. This status uses special conditions to balance out commercial...

BaseLaunch Applications open

BaseLaunch helps build therapeutic ventures to the point where they can raise a Series-A financing round or similar.

Celonic agrees cooperation to combat coronavirus

The Basel-based biopharmaceutical company Celonic Group has agreed a partnership with Airway Therapeutics from the USA. Together, the two companies...

docdok.health involved in coronavirus research project

A research project is investigating the improvement in the condition of patients who have been hospitalized due to COVID-19. docdok.health...

Idorsia receives payment of 45 million US dollars

The Allschwil-based pharmaceutical company Idorsia receives a payment of 45 million US dollars as part of an agreement with Neurocrine...

Humard robot disinfects using UV light

Humard has developed a robot that can disinfect spaces using UV light. For this, the system manufacturer from the canton...

Roche authorized to distribute coronavirus antibody tests

Roche has received Emergency Use Authorization in the USA for an antibody test in connection with the novel coronavirus. The...

Healthtech sector growing rapidly in the Basel Area

The investment and innovation promotion agency Basel Area Business & Innovation, previously known as BaselArea.swiss, can look back on a...

Support program has roots in Basel

The online program Selfapy supports people suffering from mental health conditions during the coronavirus lockdown. BaselArea.swiss has provided startup help...

University Hospital Basel treats coronavirus patients with plasma

The University Hospital Basel is the first Swiss hospital to have treated two Covid-19 patients with the plasma from a...

Botnar Research Center advancing research into coronavirus

The Basel-based Botnar Research Center for Child Health is providing capital in the amount of 15 million Swiss francs to...

CEO of Novartis pinning hopes on malaria drug

In the fight against the coronavirus, Vas Narasimhan, CEO of Novartis, is above all pinning his hopes on a malaria...

Cantons in the Basel Area agree aid measures

Basel/Liestal/Delémont – Because of the coronavirus crisis.the three sponsor cantons of BaselArea.swiss have adopted emergency aid measures in addition to...

Roivant developing treatment for coronavirus patients

The Basel-based pharmaceutical company Roivant Sciences wants to develop a special antibody for coronavirus patients. This is intended to help...

Roche Coronavirus test gets FDA approval

The US regulatory authority has authorized a test developed by the Basel-based pharmaceutical company Roche to detect the SARS-CoV 2...

University of Basel investigating active substances against the coronavirus

The University of Basel is using computer-aided methods in its efforts to find an active substance to fight the coronavirus....

Novartis and Roche are among the most innovative companies

Novartis and Roche feature among the hundred most innovative companies worldwide. This is from the Derwent Top 100 Global Innovators...

The pharma centers of Basel and India are influencing each other

Basel has long been one of the world’s most important locations within the pharmaceutical industry. But pharma firms are now...

Roche builds “best research center in the world”

The pharmaceutical giant Roche has officially started building its new research center in Basel. Around 1,800 researchers should be able...

FutureHealth conference brings international experts to Basel

The FutureHealth Basel conference brought together experts, startups and those affected by digital healthcare. In addition to exploring the opportunities...

Novartis opens campus up for innovation

Basel-based pharmaceutical Novartis is opening up its campus in Basel to external partners, including Switzerland Innovation Park Basel Area, which...

NBE-Therapeutics raises 22 million dollars

The Basel biotech company NBE-Therapeutics has successfully closed a series C financing round. The funds raised will help the company...

Sotio opens office in Basel

The Czech biotech company Sotio has opened an office in the Technologiepark Basel. Sotio Biotech AG will be responsible for...

New at Switzerland Innovation Park Basel Area: Coretag

Coretag, a new dynamic biotech company, launches a radioligand platform technology for a range of therapeutic and diagnostic purposes. A...

Basel leads in international tax competition

The canton of Basel-Stadt offers one of the world’s most attractive tax burdens for companies, according to the latest BAK...

Basel is evolving into a pediatrics hub

The Botnar Research Center for Child Health in Basel has started its research activities. The first four projects have now...

Roche diabetes app replaces blood glucose meter

Diabetes patients can use an app developed by Roche to determine their blood sugar levels on the basis of two...

BeiGene wins Scrip Award

The pharmaceutical company BeiGene has won a Scrip Award that recognizes contributions across the pharma sector to improving healthcare. BeiGene’s...

Basel areas hold promise for investors

Substantial efforts are underway in Basel to develop new areas and create space for people and companies. The efforts were...

Canton of Basel-Landschaft cuts corporate tax rates

Corporate tax rates in the canton of Basel-Landschaft will be cut from a maximum of 20.7 percent today to 13.45...

Initiative for innovative companies in Basel-Landschaft

A new initiative has been launched to support innovative SMEs and startups in the canton of Basel-Landschaft in an effort...

DayOne Accelerator finalizes participants

BaselArea.swiss manages the DayOne initiative, which is now organizing the second round of the DayOne Accelerator. The participants are Digital...

startup baselland supports company creation

BaselArea.swiss is working with selected organizations and Standortförderung Baselland to support the foundation of companies in the canton of Basel-Landschaft....

Artidis joins world’s largest medical center

The Basel-based startup Artidis is developing a medical device based on nanotechnology to help with cancer diagnoses. The spin-off from...

Jura has plenty of greenfield sites

The canton of Jura has more than 544 hectares of building land available, a study from the Federal Institute of...

Vaximm is using AI to develop cancer vaccines

Basel-based biotech company Vaximm has agreed a collaboration with IT company NEC. Vaximm wants to develop personalized cancer vaccines using...

Basel startup Nutrix beats 900 startups

The Basel startup Nutrix has won a competition at the Web Summit with its business concept. It has developed a...

The winners of the i4Challenge introduce themselves

Six companies won the i4Challenge: Arviem, Crevoisier, LCB Sarl, Qiio, Unitelabs and United Planet. We asked the winners to introduce...

Polyphor discovers new class of antibiotics

Researchers at the Allschwil pharmaceutical company Polyphor and the University of Zurich have discovered a novel antibiotics class. It has...

Switzerland Innovation Park Basel Area opens site in Jura

Switzerland Innovation Park Basel Area has opened its third location. The park is now represented in Jura alongside its locations...

Investments in Basel start-ups on the rise

Start-ups established in Basel raised more than 200 million euro in investments during the first half of 2019. Basel therefore...

Versameb raises 6.4 million Swiss francs

Basel-based biopharmaceutical Versameb has raised 6.4 million Swiss francs in a Seed C financing round and will put the funds...

Tide Ocean turns ocean plastic waste into watches

Basel-based start-up Tide Ocean turns ocean plastic waste into new products such as watches. It has now won a German...

Kindoh opens global headquarters in Basel

Kindoh, a daily consumer product brand, is moving its headquarters to Basel. The location promotion organization BaselArea.swiss supported the company’s...

Basel positions itself as international fintech hub

The Swiss National Bank is working on a fintech project with the SIX stock exchange to explore technological options to...

Novartis works with Microsoft on artificial intelligence

Novartis has selected Microsoft as its new strategic artificial intelligence (AI) and data science partner. With the collaboration, the Basel...

Six companies win the i4Challenge 2019

As part of the competition i4Challenge, BaselArea.swiss offers six start-ups and SMEs from Switzerland, Alsace or Baden-Württemberg comprehensive support, a...

T3 Pharma raises more than 12 million Swiss francs

T3 Pharma, a Basel-based biotech company, has closed its second financing round and raised in excess of 12 million Swiss...

GRID boosts innovative power of Basel region

Work on the construction of the GRID complex for innovation and commerce has begun on the BaseLink site in Allschwil...

“The Switzerland Innovation Park Basel Area and the Jura are a match made in heaven”

The Switzerland Innovation Park Basel Area will be opening its Jura site on 25 October. Claude-Henri Schaller, Director of the...

What we learned at this year’s DayOne Conference

Twenty-two panellists and speakers, among them 3 patients and digital health futurist Maneesh Juneja, 30 project champions and their mentors,...

Indigo Agriculture eröffnet Europasitz in Basel

Indigo Agriculture expandiert nach Europa und eröffnet dafür einen Hauptsitz in Basel. Das amerikanische Unternehmen bietet zukunftsweisende Technologien für die...

La transformation industrielle commence au Switzerland Innovation Park Basel Area

C’est un programme plein d’activités qui vous attend au Switzerland Innovation Park Basel Area, site du Jura, sur le Campus...

Basel startup aims to change agriculture sector

Growcer AG is currently building a machine-operated vegetable farm in Basel. Robots sow, water and fertilize the vegetables, which are...

Leading startups benefit from BaselArea.swiss

The top 100 startups of Switzerland have been revealed. In Venturelab’s Top 100, the Basel region performs particularly well in...

Basel is artificial intelligence hub

The canton of Basel-Stadt is one of the three largest Swiss technology clusters for advanced digitalization technologies, as the new...

BaseLaunch supports Switzerland as an innovation location

Switzerland often receives awards for its innovative strength. Life sciences have generally played a huge part in this acclaim. The...

Basel-based researcher combating multi-resistant bacteria

Nina Khanna Gremmelmaier has been awarded this year’s prize for science of the City of Basel. The University Hospital Basel...

Adobe develops new technology in Basel

The US-based company Adobe is developing a technology in Basel that will make it possible to display content on screens...

DayOne gains importance

DayOne, a BaselArea.swiss initiative, is creating a world-leading healthcare innovation hub based on the strengths of the Basel region. A...

Synendos Therapeutics awarded EU funding

Synendos Therapeutics AG with headquarters in Allschwil is benefiting from the financial support for which small and medium-sized enterprises can...

On the verge of being born: Next generation clinical trials

Tomasz Sablinski, Founder and CEO of Transparency Life Sciences raised the crunch question of the evening: Which industry is lagging...

Swiss TPH breaks ground on new headquarters

The Swiss Tropical and Public Health institute (Swiss TPH) has broken ground on the new building for its headquarters in...

Project uptown Basel taking shape

A competence center for Industry 4.0 is being created on the former site of ABB. Private investors have contributed around...

Switzerland Innovation Park Basel Area offre des ateliers et séminaires pour innover

Venez innover avec nous ! Tel est le slogan pour les ateliers et séminaires qui seront organisés dans le Switzerland...

“I am amazed by the level of innovation in the Jura”

The Switzerland Innovation Park Basel Area already has two sites, in Allschwil and Basel, and will soon add a third...

BaseLaunch is a world-leading accelerator

Healthcare accelerators recently came under the spotlight of technology platform Technorely. Its list of eight of the leading accelerators features...

T3 Pharmaceuticals wins W.A. de Vigier Award

T3 Pharmaceuticals is among the winners of this year’s W.A. de Vigier Award. The spin-off from the University of Basel...

BaseLaunch is top European accelerator

Healthcare Accelerator BaseLaunch, which is operated by the location promotion organization BaselArea.swiss, is among the leading accelerators of its kind...

Pfizer acquires Basel-based Therachon

U.S. pharmaceutical company Pfizer is acquiring Basel biotech Therachon for US$ 340 million. Additional payments of US$ 470 million may...

Switzerland excels with biotech start-ups

According to an article in the journal “Nature”, Switzerland is the European leader with its biotech start-up ecosystem. Based on...

Alentis raises 12.5 million Swiss francs

The Basel-based biotech company Alentis Therapeutics AG has successfully concluded a CHF 12.5 million Series A financing co-lead by BioMedPartners...

Fully equipped lab spaces at the Switzerland Innovation Park Basel Area

Launching a biotech is a daunting endeavor. Resources – both human and capital - are scarce and have to be...

Basel’s Lyfegen closes seed financing round

Lyfegen, an IT company specializing in healthcare from Basel, has raised 750,000 Swiss francs in a seed financing round. The...

Novartis subsidiary Alcon is now an independent company

Novartis completed the spin-off of the Alcon eye care devices business through a dividend-in-kind distribution. The Basel pharma giant reports...

Innolith makes breakthrough in vehicle batteries

Energy company Innolith has developed a new type of battery that gives electric vehicles a range of 1,000km. The innovation...

33 recently arrived companies create hundreds of jobs

The efforts of BaselArea.swiss proved extremely successful in 2018. 33 companies – seven more than in the previous year –...

Anaveon raises CHF 35 million

Anaveon, an immuno-oncology biotech, has successfully concluded a Series A financing round led by Syncona, a UK Life Sciences fund,...

Infographic: The Basel Biotech & Pharma Ecosystem

To develop a scientific discovery into a life-changing drug or technology, it takes experts from various fields. The Basel region...

Resistell closes successful financing round

Resistell has closed on oversubscribed seed financing round. The Basel-based startup is developing an antibiotic susceptibility test that is much...

BaselArea.swiss fights antimicrobial resistance as a part of the CARB-X Global Accelerator Network

Antibiotic resistance is fatal: If antibiotics have no effect, simple infections become deadly. According to the World Health Organization, an...

“Momentum for blockchain in healthcare is growing in Basel”

Marco Cuomo and Daniel Fritz from Novartis got engaged in blockchain two years ago. Today, their aim is set high:...

Three projects to start in the DayOne Accelerator

DayOne and BaselArea.swiss are happy to announce the winners of the first DayOne Accelerator supported by Fondation Botnar:

First semester starts well for FHNW Campus Muttenz

The semester has got off to a successful start at FHNW University of Applied Sciences and Arts Northwestern Switzerland’s new...

BaselArea.swiss welcomes BeiGene to Basel

BeiGene, Ltd., a global commercial-stage biopharmaceutical company, has established a regional headquarters in Basel. BaselArea.swiss assisted BeiGene in evaluating and...

BaseLaunch’s second round – 10 projects enter Phase I

The BaseLaunch Accelerator, managed and operated by BaselArea.swiss, started on 14 September 2018 with ten projects entering Phase I. Over...

500 words on the DayOne Conference 2018

DayOne has a history of changing and growing each year. This year the DayOne Conference took place on 11 September,...

Artificial Intelligence – the Holy Grail to Healthcare Innovation?

Last winter, Julia got a cough and a headache. For the third time she went to her physician, who sent...

“We will not shy away from taking risks”

In 2016, Roivant Sciences established their global headquarters in Basel. Roivant founder and CEO Vivek Ramaswamy talked to us about...

BaselArea.swiss Presents the DayOne Acceleration Program Supported by Fondation Botnar

Seeking brilliant project ideas that, combined with digital technologies, healthcare expertise and entrepreneurial spirit, will help solve the health challenges...

Meet the BaseLaunch Startups

Six of the BaseLaunch startups recently started Phase II. They received either grants up to 250,000 Swiss francs or gained...

BioMedPartners closes new venture capital fund

Basel-based venture capitalist firm BioMedPartners has closed its new venture capital fund BioMedInvest III at 100 million Swiss francs. The...

New prosthetic ankle is successfully implanted

The world renowned surgeon from Basel, Beat Hintermann, has successfully implanted ankle prosthesis of his own design in five patients...

BaseLaunch up to a solid Phase II start

BaseLaunch has officially started Phase II of its accelerator program, and four startups are receiving grants ranging from 120,000 to...

Roivant Sciences to join BaseLaunch Accelerator as Healthcare Partner

Roivant becomes the fifth healthcare partner of BaselArea.swiss accelerator program joining Johnson & Johnson Innovation, Novartis Venture Fund, Pfizer and...

Pharmaceutical industry is driving the Swiss economy

The number of jobs in the pharmaceutical industry is on a steady rise – and other industries are benefiting from...

13 startup projects qualify for the first phase of BaseLaunch

The BaseLaunch Healthcare Accelerator program from BaselArea.swiss started on September 14. Over 100 applications were received from more than 30...

Patient Data – Faster but with Respect and Trust

“Faster but with Respect and Trust“ - these were the final words from Effy Vayena at the DayOne Experts event...

Halozyme Therapeutics opens European headquarters

Halozyme, a U.S. biotechnology company developing novel oncology and drug-delivery therapies, has established their European headquarters office in Basel, Switzerland.

“In Switzerland, we often sell promising technologies too early”

Ulf Claesson is a "serial entrepreneur". During the past 25 years, he has set up companies that have gone on...

3D im Spital

Wo der 3D-Druck bereits heute standardmässig eingesetzt wird, in welche Richtungen sich die Technik entwickelt und welche rechtlichen Fragen dadurch...

Interest from startups in the BaseLaunch healthcare accelerator exceeds expectations

More than 100 projects from Switzerland and abroad competed for a place in the BaselArea.swiss accelerator program for healthcare startups.

Investing in strengths – Swiss leadership in life sciences

How can Switzerland and the Basel region maintain their international leadership role in life sciences? As part of the Biotech...

“I see a very innovation-friendly climate in Basel”

It all began with research resources that were a quarter of a century old. Simon Ittig and his colleagues at...

Bio-Rad Opens European headquarters in Basel, Switzerland, in April 2017

In April, Bio-Rad Laboratories, Inc., a global provider of life science research and clinical diagnostic products opened a facility in...

BaseLaunch can take full advantage of the potential of Basel’s life sciences ecosystem

The new accelerator for healthcare ventures, BaseLaunch, wants to link the best start-ups to the Basel region – and in...

BaseLaunch wants to bring the best healthcare start-ups to Basel

“If we invest billions in university research, then this remains an abortive effort if we do not make sure at...

Basel impresses with quality of living

Basel is among the top ten cities with the highest quality of living in the world, according to the latest...

Basel initiative supports life sciences start-ups

BaseLaunch, an accelerator initiative launched and run by the location promotion organisation BaselArea.swiss, is a new partner of the start-up...

Japanese company opens R&D centre in Basel

Idemitsu Kosan is a Japanese petroleum company, but it also develops and manufactures electronic materials. The company is now opening...

“Muttenz is home to the world’s largest plant for the production of 5-HMF from biomass”

Thomas Fischer is Chief Operating Officer with the biotechnology company AVA Biochem in Muttenz.

Axalta Coating Systems opens regional headquarters in the city of Basel

Philadelphia-based company Axalta Coating Systems, a leading global supplier of liquid and powder coatings is establishing its European business activities...

BaselArea.swiss welcomes Biopharmaceutical Company Ultragenyx

BaselArea.swiss Economic Promotion is pleased to announce that Ultragenyx, a biopharmaceutical company focused on the development of novel products for...

Contact us about your innovation project.